// App-Quantinova.ai

SUN-630 : Severity of Growth Hormone (GH) Deficiency (GHD) Influences the Impact of the Exon 3-Deleted GH Receptor Polymorphism on Response to GH Therapy in Children with GHD

Researchers

Presenter

  • Peter Ellis Clayton

Principal Investigators

  • Benoit Destenaves

  • Pierre Farmer

  • Adam Stevens

  • Cheri Deal

  • Alicia Belgorosky

  • Han-Wook Yoo

  • Pierre Chatelain

Medical Centers

  • Hospital Durand, Buenos Aires, Argentina

  • Royal Manchester Children's Hospital, Manchester, United Kingdom

  • Pediatrics - Neonatology, CHU Sainte-Justine - Universite de Montreal, Montreal, Canada

  • University of Manchester, Manchester, United Kingdom

  • Universite Claude Bernard Lyon , EPHE, Lyon, France

Locations

  • France

  • Canada

  • Argentina

  • United Kingdom

Companies

  • Merck & Co., Inc.

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Insulin-like growth factor 1

Drug/Treatment

  • hGH

Outcome

  • N/A

Study Design

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved